There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Only 13 states currently allow Medicaid to cover GLP-1 agonist drugs for obesity treatment, highlighting a significant gap in ...

Evidence started accumulating in the late 1980s that the GLP-1 hormone could be used to induce insulin secretion, hinting at a path to a new treatment for diabetes and attracting industry interest.

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Smoothie King, a franchise that specializes in selling smoothies, recently launched a "GLP-1 Support Menu," made specifically ...

Whether you're starting a weight loss journey or you're experiencing a plateau, the right resources make it easier to reach ...

On October 3, Amy Kane, 35, who once weighed 300 pounds at her heaviest, garnered 1.7 million views (@amyinhalf) after ...

The 12-week human clinical trial began in early June 2024 and set out to investigate if, through these mechanisms of action, ...

Drugs such as Wegovy, Ozempic, and Saxenda have quickly become household names. But are these weight loss medications right ...

In recent years, Novo Nordisk and Eli Lilly introduced drugs that act on hormones involved in the digestion process, helping ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 ...

GLP-1 receptor agonist drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food. However, the drugs are costly -- people ...